A team of researchers led by Deblina Sarkar, an electrical engineer and MIT assistant professor, developed microscopic electronic devices hybridized with living cells. Those cells can be injected into the circulatory system with a standard syringe and will travel the bloodstream before implanting themselves in target brain areas.
Not completely baffling. Intel made an attempt to create a Transmeta like hybrid software/hardware architecture at the time on one of their "VLIW" processors. It was an expensive experiment that didn't work out.
I don't think it's AGI, but rather video production. OpenAI wants to build the next video social network / ads / tv / movie production system. The moat is the massive compute required.
Huh, my read is exactly the opposite: Altman wants to be a trillionaire and isn't picky about how he gets there. If AGI accomplishes it, great, but if that's not possible, "just" making a megacorporation which permanently breaks the negotiating power of labor is fine too. Amodei is the one who I think actually wants to build AGI.
Then why start a company where you have no equity? (Yes I believe he financially benefits from OpenAI, but the more straightforward way would be OpenAI equity)
I think his initial belief was that OpenAI would to be a research organization which would get acquihired or license its tech out, and then Chat-GPT unexpectedly happened. Notice how ever since then he's been trying to get the nonprofit status cancelled or evaded.
I think your read is right. There are a few people who want to be trillionaires and aren't too picky about to get there: Elon Musk, Sam Altman, Trump, Larry Ellison, Peter Thiel, Putin. Maybe Bezos and Zuckerberg.
Of course, there wouldn't be many people who don't want to be trillionaires. Rare exceptions[1]. But these are the people with means to get there.
I definitely would not want to be a trillionaire yeah. Having a million or so would be nice but more and you get roped into all kinds of power play and you have to get security goons with you all the time to avoid getting kidnapped. I'd much rather be anonymous.
Is there any indication they are actually working on this and Altman is any good at pursuing this goal? I'm seriously asking, please inform the uninformed.
My impression is that I hear a lot more about basic research from the competing high-profile labs, while OpenAI feels focused on their established stable of products. They also had high-profile researchers leave. Does OpenAI still have a culture looking for the next breakthroughs? How does their brain trust rank?
Not a doctor but I know some- Viruses are notoriously hard to diagnose because they don't culture. Some big academic hospitals do have a virus panel where they use brute force PCR assay akin to many Covid-19 tests targeting different virus but they are very expensive hence not broadly available. Community hospitals will have the same diagnostic experience you have. At most they might be able to test for Flu or Covid but that's about it. Another reason is that even if you test positive, there is very little the hospital can do. For the most part, just tell the patient to rest and take Tylenol/Ibuprofen. The anti-virals are just limited to Flu and Covid.
The anti-virals are just limited to Flu and Covid.
There are also antivirals for Herpes simplex and zoster, HIV, Hepatitis B and C and probably others that i don't know about. It's still a small arsenal but it not limited to Flu and Covid.
Good to know. I'm repeating what an EM doc told me available in her community hospital i.e. they only have Tamiflu and Paxlovid, which is why even if she did have access to Viral panels, they couldn't do anything more to treat those other viral infections.
It would seem like the solution for 2 is for an automated takedown process on Amazon, or for Amazon to certify that their seller isn't infringing on said patent.